The National Acoustic Laboratories, in collaboration with EssilorLuxottica’s Nuance Audio brand, has published a peer-reviewed clinical trial evaluating the performance of Nuance Audio Glasses. The study has been published in the Journal of Otolaryngology ENT Research and is available as open access.
Audiologists should read the full trial rather than rely on this press release; the involvement of the device manufacturer (EssilorLuxottica) in co-publishing warrants scrutiny of outcome selection and conflict-of-interest disclosures before clinical recommendations are made.
Hearables embedded in mainstream eyewear represent a growing market segment that may attract patients who resist traditional hearing aids, making independent evidence of their performance important for the field.
- 01Clinical trial co-published by NAL and EssilorLuxottica evaluating Nuance Audio Glasses hearing performance.
- 02Published in the Journal of Otolaryngology ENT Research.
- 03Nuance Audio Glasses are eyeglasses with integrated hearing assistance technology.
- 04Manufacturer involvement in the study raises potential conflict-of-interest considerations.
- 05Represents growing evidence base for hearable/eyewear hybrid devices.
Nuance Audio Glasses improve hearing performance in users, as demonstrated by a peer-reviewed clinical trial.
studypartially supportedThe clinical trial on Nuance Audio Glasses is peer-reviewed and independently validated.
press releaseunclear- Journal
- Journal of Otolaryngology ENT Research
- Publication type
- research_article
- Evidence level
- 1b
- Population
- Individuals assessed for hearing performance with Nuance Audio Glasses (population details not specified in announcement)
- Intervention
- Nuance Audio Glasses (eyeglasses with integrated hearing assistance)
Primary outcomes
Hearing performance outcomes